Host α-adducin is redistributed and localized to the inclusion membrane in Chlamydia- and Chlamydophila-infected cells

被引:8
作者
Chu, Hencelyn G. [1 ,2 ]
Weeks, Sara K. [1 ]
Gilligan, Diana M. [3 ]
Rockey, Daniel D. [1 ]
机构
[1] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA
[2] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA
[3] Univ Washington, Puget Sound Blood Ctr, Seattle, WA 98104 USA
来源
MICROBIOLOGY-SGM | 2008年 / 154卷
关键词
D O I
10.1099/mic.0.2008/020941-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A large-scale analysis of proteins involved in host-cell signalling pathways was performed using chlamydia-infected murine cells in order to identify host proteins that are differentially activated or localized following infection. Two proteins whose distribution was altered in Chlamydia trachomatis-infected cells relative to mock-infected cells were the actin-binding protein adducin and the regulatory kinase Raf-1. Immunoblot analysis with antibodies to both phosphorylated and non-phosphorylated forms of these proteins demonstrated that the abundance of each protein was markedly reduced in the cytosolic fraction of C. trachomatis- and Chlamydophila caviae-infected cells, but the total cellular protein abundance remained unaffected by infection. Fluorescence microscopy of chlamydia-infected cells using anti-alpha-adducin antibodies demonstrated labelling at or near the chlamydial inclusion membrane. Treatment of infected cells with nocodazole or cytochalasin D did not affect alpha-adducin that was localized to the margins of the inclusion. The demonstration of alpha-adducin and Raf-1 redistribution within cells infected by different chlamydiae provides novel opportunities for analysis of host-pathogen interactions in this system.
引用
收藏
页码:3848 / 3855
页数:8
相关论文
共 30 条
[1]   Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis [J].
Beatty, WL .
JOURNAL OF CELL SCIENCE, 2006, 119 (02) :350-359
[2]   Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion [J].
Carabeo, RA ;
Mead, DJ ;
Hackstadt, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6771-6776
[3]   Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions [J].
Geisler, WM ;
Suchland, RJ ;
Rockey, DD ;
Stamm, WE .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :879-884
[4]   Targeted disruption of the β adducin gene (Add2) causes red blood cell spherocytosis in mice [J].
Gilligan, DM ;
Lozovatsky, L ;
Gwynn, B ;
Brugnara, C ;
Mohandas, N ;
Peters, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10717-10722
[5]   Adducin in platelets: activation-induced phosphorylation by PKC and proteolysis by calpain [J].
Gilligan, DM ;
Sarid, R ;
Weese, J .
BLOOD, 2002, 99 (07) :2418-2426
[6]   Inhibition of host cell cytokinesis by Chlamydia trachomatis infection [J].
Greene, W ;
Zhong, GM .
JOURNAL OF INFECTION, 2003, 47 (01) :45-51
[7]   Chlamydia trachomatis uses host cell dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process [J].
Grieshaber, SS ;
Grieshaber, NA ;
Hackstadt, T .
JOURNAL OF CELL SCIENCE, 2003, 116 (18) :3793-3802
[8]   LIPID-METABOLISM IN CHLAMYDIA TRACHOMATIS-INFECTED CELLS - DIRECTED TRAFFICKING OF GOLGI-DERIVED SPHINGOLIPIDS TO THE CHLAMYDIAL INCLUSION [J].
HACKSTADT, T ;
SCIDMORE, MA ;
ROCKEY, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4877-4881
[9]   The role of the dynactin complex in intracellular motility [J].
Holleran, EA ;
Karki, S ;
Holzbaur, ELF .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 182, 1998, 182 :69-109
[10]   Protein kinase C mediates cisplatin-induced loss of adherens junctions followed by apoptosis of renal proximal tubular epithelial cells [J].
Imamdi, R ;
de Graauw, M ;
van de Water, B .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03) :892-903